PPT-Module 3: Anemia in Chronic Kidney Disease

Andrew Narva MD FASN amp Amy Barton Pai PharmD MHI FASN FCCP FNKF Andrew Narva MD FASN No financial disclosuresconflicts of interest Amy Barton Pai PharmD MHI FASN FCCP FNKF. National Kidney and Urologic Diseases than normal. Red blood cells carry from food. With anemia, red blood cells function. Anemia tends to worsen as CKD progresses. Most people who have total 1 A pe Mohammad Asgar Khan, MD. Anemia. Learning Objectives:. Learn the pathophysiology of anemia in CKD.. Learn the diagnostic challenges of anemia in CKD.. Learn the therapeutic strategies and related controversies in the treatment of anemia in CKD.. Kevin Harley, M.D.. Assistant Clinical Professor. Department of Medicine. Division of Nephrology & Hypertension. UC Irvine Medical Center. Objectives. Review Definition of CKD and its classification. Epidemiology. CKD affects about 26 million people in the US. Approximately 19 million adults are in the early stages of the disease . On the rise do to increasing prevalence of diabetes and hypertension. Epidemiology. CKD affects about 26 million people in the US. Approximately 19 million adults are in the early stages of the disease . On the rise do to increasing prevalence of diabetes and hypertension. Chronic Kidney Disease: Detection and Management in Primary Care Julia Scialla, MD, MHS, FASN Associate Professor of Medicine and Public Health Sciences University of Virginia Adjunct Associate Professor of Medicine Chronic Kidney Failure Done by : Resources : Objectives : Extra Book Notes Important Golden Notes Differentiate Chronic kidney disease-CKD from Acute Kidney Injury-AKI. Dr. T. A. L. . Dlamini. Specialist Physician and . Nephrologist. Talk overview . Kidney function. Assessing kidney function. Chronic kidney disease (CKD). Benefits of early detection . Conclusion and take home message . Andrew . Narva. , MD, FASN & . Amy Barton . Pai. , PharmD, MHI, FASN, FCCP, FNKF. Andrew . Narva. , MD, FASN. No financial disclosures/conflicts of interest. Amy Barton . Pai. , PharmD, MHI, FASN, FCCP, FNKF. Chronic . c. are . Training . For . district . hospital . Nurses . in . Rwanda . 2013. Session 1: Defining chronic kidney disease. By the end of this Session, participants will be able to:. Screen for chronic kidney disease. . Structural . or functional abnormalities of the kidneys for . >. 3 months. . from early to late-stage disease, . Chronic Kidney Disease. as . manifested by either:. 1. Kidney . damage, with or without decreased GFR, as . DOWN. Common lab tests where age makes a difference in how we diagnose disease. J Potter. 2/3/2022. No conflicts. Do NOT blame HRSA for any errors. Background . We are most like each other when we are young. Almost 900,000 patients have end-stage renal disease (ESRD).. Patients with CKD often suffer from anemia due to poor iron utilization and erythropoietin (EPO) resistance.. Patients with CKD frequently develop elevated parathyroid hormone (PTH) levels secondary to decreased conversion of vitamin D to its active form and decreased excretion of phosphate.. Konstantia. Ass. Prof. of Nephrology D.U.TH.. Reduced quality of life . van Haalen et al. BMC Nephrology 2020. Worse renal survival. Lamerato et al. BMC Nephrology 2022. Increase in morbidity and mortality.